首页|Celiac disease markers in patients with liver diseases: A single center large scale screening study

Celiac disease markers in patients with liver diseases: A single center large scale screening study

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
  • 维普
AIM:To study the coincidence of celiac disease,we tested its serological markers in patients with various liver diseases.METHODS:Large-scale screening of serum antibodies against tissue transglutaminase (tTG),and deamidated gliadin using enzyme-linked immunosorbent assay and serum antibodies against endomysium using immunohistochemistry,in patients with various liver diseases (n =962) and patients who underwent liver transplantation (OLTx,n =523) was performed.The expression of tTG in liver tissue samples of patients simultaneously suffering from celiac disease and from various liver diseases using immunohistochemistry was carried out.The final diagnosis of celiac disease was confirmed by histological analysis of small-intestinal biopsy.RESULTS:We found that 29 of 962 patients (3％) with liver diseases and 5 of 523 patients (0.8％) who underwent OLTx were seropositive for IgA and IgG anti-tTG antibodies.However,celiac disease was biopsy-diagnosed in 16 patients:4 with autoimmune hepatitis type Ⅰ,3 with Wilson's disease,3 with celiac hepatitis,2 with primary sclerosing cholangitis,1with primary biliary cirrhosis,1 with Budd-Chiari syndrome,1 with toxic hepatitis,and 1 with non-alcoholic steatohepatitis.Unexpectedly,the highest prevalence of celiac disease was found in patients with Wilson's disease (9.7％),with which it is only rarely associated.On the other hand,no OLTx patients were diagnosed with celiac disease in our study.A pilot study of the expression of tTG in liver tissue using immunohistochemistry documented the overexpression of this molecule in endothelial cells and periportal hepatocytes of patients simultaneously suffering from celiac disease and toxic hepatitis,primary sclerosing cholangitis or autoimmune hepatitis type Ⅰ.CONCLUSION:We suggest that screening for celiac disease may be beneficial not only in patients with associated liver diseases,but also in patients with Wilson's disease.

Tissue transglutaminaseAnti-tissue transglutaminase antibodiesAutoimmune liver diseasesWilson's diseaseCeliac diseaseLiver transplantation

Pavel Drastich、Eva Honsová、Alena Lodererová、Marcela Jare(s)ová、Aneta Pekáriková、Iva Hoffmanová、Ludmila Tu(c)ková

展开 >

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine,14021 Prague, Czech Republic

Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic

Department of Immunology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic

Department of Immunology,Institute of Microbiology, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic

2nd Department of Internal Medicine, 3rd Faculty of Medicine, Charles University, 10034 Prague, Czech Republic

展开 >

Grant from the Czech Ministry of HealthAcademy of Sciences of the Czech RepublicCzech Science FoundationInstitutional Research Concept GrantInstitutional Research Concept Grant

NS9705-4/2008A500200709310/07/0414AV0Z50200510RVO:61388971

2012

10.3748/wjg.v18.i43.6255

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子：1.001
ISSN：1007-9327
年,卷(期)：2012.18(43)
  • 34